GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Tandem Diabetes Care
Tandem Diabetes Care produces touchscreen insulin pumps. Its stock price is a story of rapid growth and market share capture from larger competitors through innovation and patient convenience. The chart reflects the explosive growth in the diabetes technology sector.
Share prices of companies in the market segment - Specialized medical equipment
Tandem Diabetes Care (TNDM) develops and manufactures innovative medical equipment for people with diabetes, including sensor-based insulin pumps and data management systems. We classify the company as "Specialized Medical Equipment." The chart below shows the dynamics of the diabetes technology sector.
Broad Market Index - GURU.Markets
Tandem Diabetes Care is a healthcare company that develops and manufactures insulin pumps with touchscreens and advanced software. As a component of the GURU.Markets index, it represents the diabetes technology sector. The chart below represents the entire market. See how Tandem shares compare to the overall trend.
Change in the price of a company, segment, and market as a whole per day
TNDM - Daily change in the company's share price Tandem Diabetes Care
The daily fluctuations of Tandem Diabetes Care, a manufacturer of insulin pumps, reflect innovations in diabetes treatment. Change_co measures volatility associated with competition and technological breakthroughs. System.GURU.Markets uses this metric in formulas for evaluating fast-growing companies in the medical equipment sector.
Daily change in the price of a set of shares in a market segment - Specialized medical equipment
Tandem Diabetes Care, Inc. is an insulin pump manufacturer. This chart highlights the high volatility of the MedTech sector. Comparing it to TNDM, which competes in a fast-growing market, helps assess how its innovations are ahead of industry trends.
Daily change in the price of a broad market stock, index - GURU.Markets
Tandem Diabetes is a manufacturer of insulin pumps and continuous glucose monitoring systems. The diabetes medical device market is growing rapidly. The chart below shows the volatility in this sector, helping to assess how Tandem shares are responding to innovation and competition.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Tandem Diabetes Care
Tandem is a manufacturer of innovative insulin pumps. Its year-over-year performance reflects rapid growth and the adoption of its technology in clinical practice. The chart below tells the story of this medtech leader changing approaches to diabetes treatment.
Annual dynamics of market capitalization of the market segment - Specialized medical equipment
Tandem Diabetes Care, Inc. is a manufacturer of innovative insulin pumps and automated insulin delivery systems. Its technology is changing the lives of people with diabetes. The chart shows how its rapid growth, technological leadership, and competition with other healthcare giants are driving its superior performance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Tandem, with its insulin pumps, is a growth story in medicine. Its stock price is driven not by the economy, but by the speed of technology adoption by patients and doctors. This chart illustrates how a breakthrough technology can capture share in the vast diabetes treatment market, regardless of the economic climate.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Tandem Diabetes Care
Tandem's performance as an insulin pump manufacturer depends on the adoption of its technology. The monthly fluctuations on the chart reflect the growth in the number of its pump users and the company's ability to compete with other manufacturers, such as Insulet and Medtronic, in the rapidly growing diabetes device market.
Monthly dynamics of market capitalization of the market segment - Specialized medical equipment
Tandem Diabetes Care develops and manufactures touchscreen insulin pumps with advanced software for people with diabetes. Innovation is key to its success. The chart below illustrates the overall dynamics of the medical device sector, which also illustrates how the market values this technology leader.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Tandem Diabetes Care develops and manufactures insulin pumps. The company operates in the rapidly growing market for diabetes medical technologies. Its stock is a bet on innovation and growing product penetration. Its performance can significantly outperform the market, but it is also subject to high volatility.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Tandem Diabetes Care
Short-term fluctuations in Tandem Diabetes, an insulin pump manufacturer, reflect competition and innovation in the diabetes treatment market. News of technological breakthroughs by competitors like DexCom or Insulet, as well as user growth data, create high volatility.
Weekly dynamics of market capitalization of the market segment - Specialized medical equipment
Tandem Diabetes shares, like the entire diabetes medical technology sector, are moving against a backdrop of innovation and competition. Breakthroughs in automated glucose monitoring are driving the company. The chart below shows how the company stacks up against leaders like DexCom and Insulet.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Tandem Diabetes, as a fast-growing healthcare company, can grow independently of the market for a long time, driven by innovation. However, during periods of general risk aversion, even such companies can fall along with the rest. The chart will show when its story gives way to market panic.
Market capitalization of the company, segment and market as a whole
TNDM - Market capitalization of the company Tandem Diabetes Care
The Tandem Diabetes market capitalization chart is a financial valuation of a diabetes treatment innovator. It reflects the success of its touchscreen insulin pumps and automated insulin delivery systems. Its dynamics tell the story of how technology and user-friendliness can capture market share from much larger competitors.
TNDM - Share of the company's market capitalization Tandem Diabetes Care within the market segment - Specialized medical equipment
Tandem Diabetes Care produces innovative insulin pumps with touchscreens and integration with continuous glucose monitoring systems. Its market share in diabetes products reflects its technological leadership. The chart shows how well its user-friendly devices compete with products from giants Medtronic and Insulet.
Market capitalization of the market segment - Specialized medical equipment
Tandem Diabetes Care is a manufacturer of innovative insulin pumps and diabetes management systems. The chart below shows the overall market capitalization of the specialized medical equipment sector. Its growth reflects technological advances in diabetes treatment, and Tandem is at the forefront of this revolution.
Market capitalization of all companies included in a broad market index - GURU.Markets
Diabetes treatment, as illustrated by the graph, is becoming increasingly technologically advanced. Tandem Diabetes Care produces insulin pumps with touchscreens and integration with glucose monitoring systems. Its capitalization is based on its convenient and technologically advanced devices that improve patients' quality of life.
Book value capitalization of the company, segment and market as a whole
TNDM - Book value capitalization of the company Tandem Diabetes Care
Tandem Diabetes is the material foundation for innovation in insulin pumps. Its growing book value reflects the expansion of its production facilities and R&D centers. These physical assets enable the creation of compact and intelligent devices that improve the lives of people with diabetes.
TNDM - Share of the company's book capitalization Tandem Diabetes Care within the market segment - Specialized medical equipment
Tandem Diabetes Care controls the manufacturing facilities for its innovative insulin pumps. Its stake in the sector's assets includes factories and R&D centers. This physical base is key to the creation and delivery of devices that change the lives of people with diabetes.
Market segment balance sheet capitalization - Specialized medical equipment
Tandem Diabetes Care produces insulin pumps. The medical equipment sector, as the chart shows, is capital-intensive. Tandem is a classic player. Its business consists of R&D and factories that produce its innovative devices, which are its primary tangible product.
Book value of all companies included in the broad market index - GURU.Markets
Tandem Diabetes Care develops and manufactures insulin pumps with touchscreens and automated glucose monitoring technology. Its net worth comes from its manufacturing capacity and R&D investments to create more convenient and intelligent devices for people with diabetes.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Tandem Diabetes Care
Tandem Diabetes Care is a manufacturer of insulin pumps. Its high premium reflects its innovative products, rapid growth, and ability to capture market share from larger competitors.
Market to book capitalization ratio in a market segment - Specialized medical equipment
Tandem Diabetes Care develops and manufactures insulin pumps and related products. It is a high-tech medical device company. The chart shows the market premium for its innovative products that improve the lives of people with diabetes, compared to its tangible assets.
Market to book capitalization ratio for the market as a whole
Tandem Diabetes Care produces insulin pumps with sensor technology that automate insulin delivery. Compared to average market valuations, as shown in this chart, its high premium reflects its technological leadership and rapid market share gains from larger competitors.
Debts of the company, segment and market as a whole
TNDM - Company debts Tandem Diabetes Care
Tandem Diabetes Care develops and markets insulin pumps and related products. This is a high-tech medical sector that requires constant investment in R&D to improve devices and software. This chart illustrates how the company funds its innovation and manufacturing needs to compete in the diabetes treatment device market.
Market segment debts - Specialized medical equipment
Tandem Diabetes Care produces insulin pumps and related products. This is a rapidly growing but highly competitive market. The company invests heavily in R&D to develop new generations of devices. This chart shows how Tandem funds its innovation and growth in the medical device market.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Tandem Diabetes Care
Tandem Diabetes Care develops and markets insulin pumps. This chart shows the financial structure of the medical device manufacturer. For a company operating in an innovative and competitive market, financial flexibility is important. Debt levels can impact its ability to invest in research and development of the next generation of devices.
Market segment debt to market segment book capitalization - Specialized medical equipment
Tandem Diabetes Care produces insulin pumps and technologies for people with diabetes. The diabetes medical device market is rapidly growing and becoming increasingly technologically advanced. This chart shows the overall debt burden in the sector. It helps assess how Tandem finances its innovation and competition with major players like Medtronic.
Debt to book value of all companies in the market
Tandem Diabetes Care, Inc. is a manufacturer of insulin pumps and other equipment for people with diabetes. This is a rapidly growing market, requiring investment in R&D and marketing. This chart helps understand how the company is funding its growth: whether it uses its positive cash flow or raises debt to accelerate innovation and capture market share.
P/E of the company, segment and market as a whole
P/E - Tandem Diabetes Care
This chart for Tandem Diabetes Care, a manufacturer of insulin pumps, shows the premium valuation typical of a growing medical technology company. The high P/E reflects the rapid growth of its device sales and investors' belief that its technologies make life easier and safer for people with diabetes.
P/E of the market segment - Specialized medical equipment
Tandem Diabetes Care develops and manufactures innovative insulin pumps and other products for people with diabetes. The company is known for its touchscreen devices and integration with glucose monitoring systems. This chart shows the average rating for the sector, helping to understand how the market values Tandem's technological innovations.
P/E of the market as a whole
Tandem Diabetes Care develops and markets touchscreen insulin pumps and associated software for diabetes management. Its growth depends on its ability to capture market share from competitors and innovations in automated insulin delivery. Its business is driven by medical needs, not by the general economic cycles reflected in this chart.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Tandem Diabetes Care
Tandem Diabetes Care develops and manufactures insulin pumps and related products for people with diabetes. The company's growth is fueled by innovation and patient adoption of more convenient technologies. This chart reflects market expectations regarding the future adoption of their technologies and the company's ability to increase its share of the diabetes management market.
%20P%2FE%20Tandem%20Diabetes%20Care&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Tandem-Diabetes-Care&v=1772695663347 "Chart of the company's future (projected) P/E Tandem Diabetes Care")
Future (projected) P/E of the market segment - Specialized medical equipment
Tandem Diabetes Care develops and markets innovative sensor-integrated insulin pumps for people with diabetes. This chart shows general expectations for the medical device sector. TNDM's position relative to the average reflects whether investors believe their sensor-controlled technology will become the standard in diabetes treatment, displacing traditional methods.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Specialized-medical-equipment&v=1772695663396 "Future (projected) P/E graph of the market segment - Specialized medical equipment")
Future (projected) P/E of the market as a whole
Tandem Diabetes Care develops and sells insulin pumps. Demand for its products is supported by rising diabetes rates and technological innovation. This chart helps investors assess how the market values strong growth medtech companies relative to the broader market.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772695663413 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Tandem Diabetes Care
Tandem Diabetes Care develops and manufactures touch-sensitive insulin pumps for people with diabetes. Its profit chart illustrates the success of its innovative products, such as the t:slim X2, which automates insulin delivery. Growing user base and sales of consumables are key to profitability.
Profit of companies in the market segment - Specialized medical equipment
Tandem Diabetes Care develops and markets innovative insulin pumps and related products for people with diabetes. The company is a strong player in the diabetes technology market. This chart shows the collective revenue in the specialized medical equipment sector. It illustrates how technological innovations are changing chronic disease management and how cost-effective this is.
Overall market profit
Tandem Diabetes Care produces insulin pumps and other products for people with diabetes. Demand for its products is driven by medical needs and is largely unaffected by short-term economic cycles. The company's growth is driven by innovation and market penetration. However, the overall economic situation, as shown in this chart, may influence insurance companies' coverage decisions.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Tandem Diabetes Care
Tandem Diabetes Care develops and markets insulin pumps and related products for people with diabetes. The company's growth is driven by product innovation, such as integration with glucose monitoring systems. This chart shows analysts' expectations for future sales, reflecting their belief in Tandem's technological leadership in the market.
%20profit%20of%20the%20company%20Tandem%20Diabetes%20Care&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Tandem-Diabetes-Care&v=1772695663514 "Graph of future (projected) profit of the company Tandem Diabetes Care")
Future (predicted) profit of companies in the market segment - Specialized medical equipment
Tandem Diabetes Care develops and markets touchscreen insulin pumps with advanced software for people with diabetes. The company's growth is driven by technological innovation and patient adoption of more user-friendly devices. This chart reflects forecasts for the medical device sector, allowing you to assess how Tandem competes in the diabetes technology market.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Specialized-medical-equipment&v=1772695663541 "Graph of future (predicted) profits of companies in a market segment - Specialized medical equipment")
Future (predicted) profit of the market as a whole
Tandem Diabetes Care develops and markets insulin pumps and related products. Demand for its products is driven by medical needs and is not significantly affected by economic cycles. However, the overall economic situation, as reflected in this chart, may impact insurance coverage and patient solvency.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772695663546 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Tandem Diabetes Care
Tandem Diabetes Care develops and sells insulin pumps and related products for people with diabetes. This chart shows how the market values its innovative technologies and ability to compete with larger players. The high multiple reflects confidence in the growth of the diabetes treatment device market and market share capture.
P/S market segment - Specialized medical equipment
Tandem Diabetes Care develops and sells touchscreen insulin pumps and related products for people with diabetes. Revenue comes from sales of these high-tech medical devices. This chart for the medical devices sector helps assess how investors value Tandem's innovative products and their ability to improve patients' quality of life.
P/S of the market as a whole
Tandem Diabetes Care develops and manufactures innovative touchscreen insulin pumps with integration with continuous glucose monitoring systems. This market revenue valuation chart helps understand the premium investors are willing to pay for a technology leader improving the quality of life for people with diabetes and capturing market share from larger competitors.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Tandem Diabetes Care
Tandem Diabetes Care develops and manufactures touchscreen insulin pumps with advanced technology that help people with diabetes manage their condition. This chart shows how investors view the future sales of these high-tech medical devices. It reflects their belief in the superiority of Tandem's products and the growth of the diabetes treatment market.
%20P%2FS%20Tandem%20Diabetes%20Care&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Tandem-Diabetes-Care&v=1772695663653 "The graph of the company's future (projected) P/S Tandem Diabetes Care")
Future (projected) P/S of the market segment - Specialized medical equipment
Tandem Diabetes Care develops and markets touchscreen insulin pumps with predictive glucose monitoring technology. The company's high valuation reflects investors' faith in its innovative products that make life easier for people with diabetes and its ability to capture market share from larger competitors like Medtronic.
%20P%2FS%20market%20segment%20graph%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Specialized-medical-equipment&v=1772695663656 "Future (projected) P/S market segment graph - Specialized medical equipment")
Future (projected) P/S of the market as a whole
Tandem Diabetes Care develops and markets insulin pumps and related products. The company's growth is driven by the introduction of more convenient and effective diabetes management technologies. Given the overall forecasts shown in the chart, Tandem represents an innovative sector of medical technology.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772695663657 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Tandem Diabetes Care
Tandem Diabetes Care develops and markets diabetes treatment devices. This chart shows revenue from sales of its flagship t:slim X2 touchscreen insulin pumps, as well as disposable cartridges and infusion sets. Growth is driven by technological advances and patient transitions from traditional methods.
Sales of companies in the market segment - Specialized medical equipment
Tandem Diabetes Care (TNDM) develops and manufactures innovative insulin pumps and systems for people with diabetes. Their flagship product, the t:slim X2 pump, integrates with continuous glucose monitoring systems to automate insulin delivery. This figure reflects revenue in the medical device market, where Tandem's technologies significantly improve the quality of life for people with diabetes.
Overall market sales
Tandem Diabetes Care develops and manufactures insulin pumps and related products for people with diabetes. Demand for its high-tech products is driven by medical needs, but also by affordability. This general economic activity influences insurance coverage and government healthcare spending, making its products accessible to patients.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Tandem Diabetes Care
Tandem Diabetes Care develops and markets touchscreen insulin pumps and related products for people with diabetes. The company's future sales depend on the adoption of its technologies and competition in the diabetes treatment device market. This chart reflects analyst revenue forecasts, which indicate patient adoption of more advanced glycemic control systems.
%20sales%20of%20the%20company%20Tandem%20Diabetes%20Care&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Tandem-Diabetes-Care&v=1772695663784 "Schedule of future (projected) sales of the company Tandem Diabetes Care")
Future (projected) sales of companies in the market segment - Specialized medical equipment
Tandem Diabetes Care develops and markets touchscreen insulin pumps and related products. This chart segments projected sales by product (pumps, cartridges) and by geographic region. This allows analysts to assess how demand for their innovative diabetes treatment devices is expected globally.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Specialized-medical-equipment&v=1772695663789 "Schedule of future (projected) sales of companies in the market segment - Specialized medical equipment")
Future (projected) sales of the market as a whole
Tandem Diabetes Care develops and manufactures insulin pumps and related products for people with diabetes. Demand for their products is driven by the advantages of their technology and the rising prevalence of diabetes. This graph, reflecting the state of the economy, influences insurance coverage and patient willingness to upgrade to more expensive and advanced devices.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772695663796 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Tandem Diabetes Care
Tandem Diabetes Care develops and manufactures touchscreen insulin pumps and related products for people with diabetes. The company's profitability depends on innovation, market competition, and insurance reimbursement. The chart shows how the company, by improving patients' quality of life, turns its high-tech medical devices into profit.
Market segment marginality - Specialized medical equipment
Tandem Diabetes Care develops and manufactures touchscreen insulin pumps with continuous glucose monitoring system integration. This chart shows the company's profitability. Success in competing with medical device giants depends on the technological superiority, ease of use, and clinical benefits of its products.
Market marginality as a whole
Tandem Diabetes Care develops and markets insulin pumps and related products. Demand for its products is growing due to technological advances and the prevalence of diabetes. This overall profitability chart reflects the state of the healthcare system. The financial stability of insurance companies and hospitals ensures coverage of expensive medical devices.
Employees in the company, segment and market as a whole
Number of employees in the company Tandem Diabetes Care
Tandem Diabetes Care develops and manufactures insulin pumps and other diabetes treatment equipment. Its growing team reflects rapid sales growth and the adoption of its technology. This chart shows how the company is hiring engineers, salespeople, and support staff to meet high demand.
Share of the company's employees Tandem Diabetes Care within the market segment - Specialized medical equipment
Tandem Diabetes Care develops and manufactures insulin pumps and other products for people with diabetes. Success in this field depends not only on technology but also on the highest level of customer support. This chart shows the team of engineers, production personnel, and, most importantly, patient support specialists behind the company's products.
Number of employees in the market segment - Specialized medical equipment
Tandem Diabetes Care develops and manufactures insulin pumps and related products. This chart, reflecting employment in the specialized medical equipment sector, demonstrates the pace of innovation in diabetes treatment. For Tandem, growth in this field means both market expansion through new technologies and fierce competition from other pump and monitoring system manufacturers.
Number of employees in the market as a whole
Tandem Diabetes Care develops and manufactures advanced insulin pumps. The company's growth is driven by technological innovation and its adoption by the growing population of people with diabetes. Its business is based on non-discretionary medical need, making it resilient to economic cycles, as illustrated in this chart.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Tandem Diabetes Care (TNDM)
Tandem Diabetes Care is a manufacturer of innovative touchscreen insulin pumps and automated insulin delivery systems. It is a high-tech medical device company. This indicator reflects the market's appreciation for the company's patents, software, and brand, which have enabled it to maintain a leading position in the diabetes treatment market.
%20of%20the%20company%20Tandem%20Diabetes%20Care%20(TNDM)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Tandem-Diabetes-Care-TNDM&v=1772695663908 "Chart of market capitalization per employee (in thousands of dollars) of the company Tandem Diabetes Care (TNDM)")
Market capitalization per employee (in thousands of dollars) in the market segment - Specialized medical equipment
Tandem Diabetes Care produces insulin pumps and related products. This is a high-tech medical product. Its high market capitalization per employee reflects the value of its technology and patents. The chart shows the market premium the company places on innovations that improve the lives of people with diabetes.
%20by%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Specialized-medical-equipment&v=1772695663942 "Market capitalization per employee (in thousands of dollars) by market segment - Specialized medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
Tandem Diabetes Care develops and manufactures insulin pumps and related products for people with diabetes. This chart shows how the market values this innovative medical device manufacturer. The high cost per employee reflects the value of its technology, patents, and brand, which help improve patients' quality of life.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772695663970 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Tandem Diabetes Care (TNDM)
Tandem Diabetes Care produces insulin pumps (t:slim X2) and related software. It's a high-tech medical business. This chart shows how effectively the company sells its devices and, more importantly, its high-margin consumables (cartridges). It's an indicator of the strength of their technology and their success in competing with other manufacturers.
%20Chart%20Tandem%20Diabetes%20Care%20(TNDM)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Tandem-Diabetes-Care-TNDM&v=1772695663980 "Company Profit Per Employee (in thousands of dollars) Chart Tandem Diabetes Care (TNDM)")
Profit per employee (in thousands of dollars) in the market segment - Specialized medical equipment
Tandem Diabetes Care (TNDM) is a manufacturer of insulin pumps (t:slim X2), competing with Medtronic. This is a high-tech medical device. The business model is based on selling the hardware (pump) and consumables. This metric reflects how successfully R&D and sales are promoting this technology.
%20in%20the%20market%20segment%20-%20Specialized%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Specialized-medical-equipment&v=1772695664006 "Chart of profit per employee (in thousands of dollars) in the market segment - Specialized medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
Tandem Diabetes Care develops and manufactures sensor-integrated insulin pumps (t:slim) for diabetes treatment. This is a high-tech medical device. The business is built on R&D and a strong brand in the diabetes community. This chart shows how, in the MedTech sector, an innovative product (pump) enables high profitability per employee.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772695664011 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Tandem Diabetes Care (TNDM)
Tandem Diabetes Care develops and markets touchscreen insulin pumps with predictive glucose monitoring technology. This medical technology company's revenue per employee reflects the rapid adoption of its innovative products. The chart shows how the company is gaining market share from competitors by offering more convenient solutions for people with diabetes.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Tandem-Diabetes-Care-TNDM&v=1772695664033 "Sales chart per company employee Tandem Diabetes Care (TNDM)")
Sales per employee in the market segment - Specialized medical equipment
Tandem Diabetes Care (TNDM) develops and manufactures insulin pumps (t:slim) and diabetes management technologies. This chart shows the average revenue per employee in the medical device segment. It helps evaluate how effectively Tandem generates sales of its innovative devices compared to other manufacturers in this niche.
Sales per employee for the market as a whole
Tandem Diabetes Care (TNDM) develops and markets cutting-edge insulin pumps (t:slim X2) and diabetes treatment technologies. This is a high-tech medical device. This metric demonstrates the commercial success of their innovations. It shows how much revenue the TNDM team generates from pump and consumable sales (which provide recurring revenue).
Short shares by company, segment and market as a whole
Shares shorted by company Tandem Diabetes Care (TNDM)
Tandem Diabetes (TNDM) is a manufacturer of insulin pumps (t:slim X2), a direct competitor to Medtronic and Insulet. This is an innovative but highly competitive market. This chart shows a bearish sentiment. The increase in short positions may reflect investor concerns about pricing pressure from competitors or the emergence of new technologies (such as from Beta Bionics) that will make Tandem pumps less attractive. (348)
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Tandem-Diabetes-Care-TNDM&v=1772695664146 "Short Shares Chart for the Company Tandem Diabetes Care (TNDM)")
Shares shorted by market segment - Specialized medical equipment
Tandem is a manufacturer of smart insulin pumps (t:slim X2) that automate insulin delivery, competing with Medtronic and Insulet. This chart shows the overall sentiment in the sector, reflecting investor concerns about fierce competition or the impact of new drugs (Ozempic) on the pump market.
Shares shorted by the overall market
Tandem Diabetes (TNDM) produces high-tech insulin pumps that change the lives of people with diabetes. It's a fast-growing market, but one with fierce competition (Medtronic, Insulet). This chart shows the bets that their growth will slow. Bears may believe that competitors will offer more advanced technology or that pressure from insurance companies will lower the prices of TNDM pumps.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Tandem Diabetes Care (TNDM)
Tandem Diabetes Care is an insulin pump manufacturer that made a breakthrough by integrating them with CGM (glucose monitoring). This chart measures how the market views them in the diabetes technology race. It shows when the stock is overbought on growth expectations or oversold on fears that competitors (Medtronic, Insulet) will overtake them.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Tandem-Diabetes-Care-TNDM&v=1772695664153 "RSI 14 indicator chart for the company's stock Tandem Diabetes Care (TNDM)")
RSI 14 Market Segment - Specialized medical equipment
Tandem Diabetes Care is a medical device manufacturer specializing in insulin pumps. Their t:slim X2 pumps, featuring closed-loop technology (integrated with CGM), are a direct competitor to Medtronic. This chart measures the overall momentum in the specialized medical device sector. It helps assess how the market views the industry and whether Tandem stands out from the crowd.
RSI 14 for the overall market
Tandem Diabetes (TNDM), a manufacturer of insulin pumps. This chart shows that its business is "defensive." Demand for its products isn't dependent on euphoria or panic—it depends on the number of diabetics. During times of market panic, investors seek safe havens in companies with completely non-cyclical demand, like TNDM.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast TNDM (Tandem Diabetes Care)
Tandem Diabetes (TNDM) is an insulin pump manufacturer and a key competitor in the treatment of type 1 diabetes. This chart shows the average 12-month forecast. It reflects analysts' views on the pace of pump adoption, competition, and innovation in the artificial pancreas field.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-TNDM-Tandem-Diabetes-Care&v=1772695664213 "A chart showing analyst consensus forecasts for the expected stock price. TNDM (Tandem Diabetes Care)")
The difference between the consensus estimate and the actual stock price TNDM (Tandem Diabetes Care)
Tandem Diabetes Care is a manufacturer of innovative insulin pumps (t:slim X2) with automatic dosing technology. Their devices make life easier for people with type 1 diabetes. This chart illustrates the analyst community's opinion on the company's future. It measures the distance between the current share price and the consensus target price, demonstrating whether experts believe in their technology.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-TNDM-Tandem-Diabetes-Care&v=1772695664218 "A chart showing the difference between the consensus forecast and the actual stock price. TNDM (Tandem Diabetes Care)")
Analyst consensus forecast for stock prices by market segment - Specialized medical equipment
Tandem Diabetes is a leader in smart insulin pumps. Their t:slim X2 system automatically regulates insulin delivery, mimicking a healthy pancreas. This chart shows general expectations for the specialized medical device sector. It reflects whether experts believe in the future of pumps amid competition from newer medications (GLP-1).
Analysts' consensus forecast for the overall market share price
Tandem Diabetes Care is a manufacturer of innovative insulin pumps (t:slim X2) that work in a closed-loop fashion with glucose monitors (DexCom). This represents high-tech in diabetes treatment. This chart shows the overall market sentiment. For Tandem, which operates in the competitive medtech sector, it's important to understand how these expectations (healthcare budgets) influence the adoption of their expensive devices. (349)
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Tandem Diabetes Care
Tandem Diabetes (TNDM) is an innovative company that disrupted the insulin pump market. Their t:slim (with DexCom CGM integration) was the first smart pump to create an artificial pancreas. This chart is an indicator of their market share. It measures their ability to win patients from giants like Medtronic and their transition from hardware sales to a subscription model.
AKIMA Market Segment Index - Specialized medical equipment
Tandem Diabetes (TNDM) is a medtech innovator in diabetes; the company (a competitor of Insulet) produces high-tech insulin pumps (t:slim X2), which (when paired with the DexCom CGM) act as an artificial pancreas. This composite metric evaluates companies. The graph shows the sector average. This benchmark: how does this technologically advanced (razor-like) model (TNDM) differentiate it from the average competitor?
The AKIM Index for the overall market
Tandem Diabetes Care is a manufacturer of touch-sensitive insulin pumps. It competes with Medtronic and Insulet. This chart, which reflects the market average, serves as a backdrop. It helps assess how this technological development in diabetes, dependent on new products and competition, compares to overall macroeconomic trends.
